EUCTR2012-002513-19-SE进行中（未招募）不适用
68Ga-DOTATOC-PET/CT for diagnosis of neuroendocrina tumours
Karolinska University Hospital Solna0 个研究点开始时间: 2012年8月7日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with neueoendocrine tumour in need of somatostatin receptor imaging for staging of the disease, depiction of the primary tumour and patients with medullary thyroid cancer in need for pre-operative lymph node mapping.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 200
排除标准
- •Age less than 18 years
- •Claustrofobia
研究者
相似试验
进行中（未招募）
不适用
68Ga-DOTANOC as a PET tool to diagnose nueroendocrine tumors - NDStudy of tumor neuroendocrin originEUCTR2010-022975-67-ITAZIENDA U.L.S.S. N.8 DI ASOLO
已完成
2 期
68Ga-DOTATATE PET Scan in Neuroendocrine CancerNeuroendocrine CarcinomaNCT01396382Vanderbilt-Ingram Cancer Center97
No Longer Available
不适用
68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access TrialNeuroendocrine TumorsNCT02358018Memorial Sloan Kettering Cancer Center
Unknown
1 期
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine TumorsNeuroendocrineNeuroendocrine CancerNeuroendocrine CarcinomaCarcinoid TumorIslet Cell TumorApudomaNeuroendocrine TumorCarcinoidNCT02038738Ochsner Health System250
进行中（未招募）
1 期
Octreotide PET/CT scan for the imaging of disease activity in neurologic and cardiac sarcoidosis.Sarcoidosis.EUCTR2016-002160-14-NLSt. Antonius Hospital